- Home
- SRE vs BDX Comparison
SRE vs BDX Comparison
Compare SRE & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRE | BDX |
|---|---|---|
| Founded | 1998 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.3B | 54.6B |
| IPO Year | 2008 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SRE | BDX |
|---|---|---|
| Price | $78.62 | $212.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 16 |
| Target Price | $97.42 | ★ $195.57 |
| AVG Volume (30 Days) | ★ 3.0M | 1.7M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.29% | 1.99% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.58 | ★ 1.59 |
| Revenue | $13,702,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $0.02 | $1.39 |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | ★ $52.49 | $131.57 |
| Revenue Growth | 3.92 | ★ 8.24 |
| 52 Week Low | $76.21 | $140.11 |
| 52 Week High | $101.04 | $213.08 |
Technical Indicators
Market Signals| Indicator | SRE | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 34.05 | 73.36 |
| Support Level | $76.21 | $175.60 |
| Resistance Level | $87.12 | $213.08 |
| Average True Range (ATR) | 1.48 | 4.32 |
| MACD | -0.56 | 1.46 |
| Stochastic Oscillator | 7.45 | 86.32 |
Price Performance
Historical ComparisonAbout SRE DBA Sempra
Sempra serves one of the largest utility customer bases in the United States. It distributes natural gas and electricity in Southern California and owns 80% of Oncor, a transmission and distribution business in Texas. Sempra Infrastructure Partners, 25% owned by Sempra, owns and operates liquefied natural gas facilities in North America and infrastructure in Mexico.
About BDX Becton Dickinson and Company
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.